Transaction Case Studies
IPO Advisory assignment helping raise $210M in a NASDAQ IPO
Situation Assessment
- Following the completion of a $170M Series B crossover round, C4 Therapeutics was eager to enter the public markets as quickly as possible
- Two competitors were also preparing to go public, so it was crucial for C4 to stand out in the marketplace and file the S-1 in a timely fashion
- C4 desired to build the best syndicate possible to position the company for aftermarket success
- Locust Walk advised C4 on their crossover and was uniquely positioned to advise C4 through the IPO process
- Created the initial draft of the Business Overview for the S-1, beginning in advance of the closing of the crossover round to maximize speed
- Led a comprehensive banker bake-off, provided introductions, identified key selection criteria, coordinated banker interviews, and guided discussions with the Board for banker selection
- Conducted comprehensive financial analysis and assisted company with negotiation of banker syndicate economics
- Participated in drafting sessions with banker syndicate to file the S-1 within 30 days of the org meeting
- Created TTW and IPO roadshow deck in parallel to S-1 drafting
- Created deeper scientific presentation for the pre-IPO Analyst Day
- The company was on file with the SEC in less than three months from closing from crossover round and less than two months after the org meeting
- Successful TTW process has built significant demand for the offering in advance of official IPO roadshow launch